2m 2m 2m 2m 2m 2m 2m
Novartis Sp ADR (NVS)
NYSE
$153.44+$4.50 (+3.02%)
Price as of Jun 23, 2026 4:15 PM EDT- $284.2BMarket Cap
- 30.56%1-Year Change
- Drug Manufacturers - GeneralIndustry
Novartis Sp ADR (NVS)
$153.44+$4.50 (+3.02%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cost of Revenue | 13.7B +6.80% | 12.8B +2.85% | 12.5B -19.46% | 15.5B -2.40% | |
Gross Profit | 43.0B +10.49% | 38.9B +13.77% | 34.2B -5.93% | 36.3B -1.80% | |
Sales and Marketing Expense | 13.2B +5.43% | 12.6B +0.39% | 12.5B -12.18% | 14.3B -4.25% | |
Research and Development Expense | -11.2B +11.75% | -10.0B -11.86% | -11.4B +13.76% | -10.0B +4.78% | |
Depreciation and Amortization Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Operating Expenses | 13.2B +5.43% | 12.6B +0.39% | 12.5B -12.18% | 14.3B -4.25% | |
Operating Profit | 17.6B +21.31% | 14.5B +48.88% | 9.8B +6.22% | 9.2B -21.32% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | -1.1B +13.72% | -1.0B +17.66% | -855.0M +2.15% | -837.0M +3.21% | |
Interest Income and Expense and Net | -1.1B +13.72% | -1.0B +17.66% | -855.0M +2.15% | -837.0M +3.21% | |
Total Nonoperating Income and Expense | 1.1B +13.72% | 1.0B +17.66% | 855.0M +2.15% | 837.0M +3.21% | |
Income before Taxes | 14.0B +16.99% | 11.9B -19.62% | 14.9B +113.57% | 7.0B -71.04% | |
Income Taxes | 2.4B +40.21% | 1.7B +208.71% | 551.0M -61.09% | 1.4B -33.18% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | 14.0B +16.99% | 11.9B -19.62% | 14.9B +113.57% | 7.0B -71.04% | |
Net Income from Continuing Operations Applicable to Common | 14.0B +16.99% | 11.9B -19.62% | 14.9B +113.57% | 7.0B -71.04% | |
Basic EPS and Net Income | 7.21 +21.79% | 5.92 -17.20% | 7.15 +124.14% | 3.19 -70.21% | |
Diluted EPS and Net Income | 7.15 +21.81% | 5.87 -17.32% | 7.10 +123.97% | 3.17 -70.18% | |
Basic Weighted Average Shares | 1.9B -3.91% | 2.0B -2.84% | 2.1B -4.77% | 2.2B -2.76% | |
Diluted Weighted Average Shares | 1.9B -3.91% | 2.0B -2.84% | 2.1B -4.77% | 2.2B -2.76% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 11.4B -0.21% | 11.5B -14.44% | 13.4B +78.17% | 7.5B -39.41% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 11.4B -0.21% | 11.5B -14.44% | 13.4B +78.17% | 7.5B -39.41% | |
Total Current Assets | 30.5B +2.55% | 29.7B -2.55% | 30.5B -17.42% | 36.9B -19.27% | |
Accumulated Depreciation | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Property and Plant and Equipment and Net | 10.8B +14.00% | 9.5B -0.59% | 9.5B -11.61% | 10.8B -6.76% | |
Total Long-Term Assets | 80.5B +10.96% | 72.5B +4.43% | 69.5B -13.76% | 80.5B -6.43% | |
Total Assets | 110.9B +8.51% | 102.2B +2.30% | 99.9B -14.91% | 117.5B -10.88% | |
Income Taxes Payable | N/A N/A | N/A N/A | 516.0M -38.28% | 836.0M +35.06% | |
Total Short-Term Debt | 682.0M +6.23% | 642.0M +2.88% | 624.0M -27.69% | 863.0M -4.00% | |
Total Current Liabilities | 27.3B -4.93% | 28.7B +8.72% | 26.4B -7.91% | 28.7B -5.14% | |
Total Long-Term Debt | 500.0M -4.40% | 523.0M -84.15% | 3.3B N/A | N/A N/A | |
Total Long-Term Liabilities | 37.1B +26.15% | 29.4B +9.79% | 26.8B -8.75% | 29.4B -13.00% | |
Total Liabilities | 64.4B +10.81% | 58.1B +9.26% | 53.2B -8.33% | 58.0B -9.29% | |
Retained Earnings | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Stockholders Equity | 46.5B +5.49% | 44.1B -5.61% | 46.8B -21.33% | 59.4B -12.38% | |
Total Shares Outstanding | 1.9B -3.39% | 2.0B -3.37% | 2.0B -3.57% | 2.1B -5.16% | |
Cash Flow | |||||
Cash from Operating Activities | 19.1B +8.66% | 17.6B +21.86% | 14.5B +1.56% | 14.2B -5.54% | |
Capital Expenditures | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Investing Activities | -4.9B -35.09% | -7.5B -234.26% | 5.6B +281.20% | 1.5B -65.11% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | -14.9B +26.61% | -11.7B -17.76% | -14.3B -30.56% | -20.6B +26.43% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Return on Assets | 13.10% +10.95% | 11.81% -13.58% | 13.67% +144.86% | 5.58% -69.35% | |
Return on Equity | 30.81% +17.25% | 26.28% -6.09% | 27.98% +155.96% | 10.93% -71.67% | |
Revenue Growth | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Current Ratio | 1.12 +7.86% | 1.04 -10.36% | 1.16 -10.33% | 1.29 -14.89% | |
Cash Ratio | 0.42 +4.96% | 0.40 -21.30% | 0.51 +93.48% | 0.26 -36.13% | |
Debt-to-Equity Ratio | 0.03 -3.79% | 0.03 -68.53% | 0.08 N/A | N/A N/A | |
Debt-to-Assets Ratio | 0.01 -6.14% | 0.01 -70.99% | 0.04 N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow